NASDAQ: ISRG - Intuitive Surgical

Yield per half year: +38.87%
Sector: Healthcare

Share chart Intuitive Surgical


About

Intuitive Surgical, Inc. - американская корпорация, которая разрабатывает, производит и продает роботизированные продукты, предназначенные для улучшения клинических исходов пациентов с помощью минимально инвазивной хирургии, в первую очередь с помощью хирургической системы da Vinci.

More details
Компания входит в индексы NASDAQ-100 и S&P 500. По состоянию на 31 декабря 2019 года в компании Intuitive Surgical было установлено 5582 хирургических системы da Vinci, в том числе 3531 в США, 977 в Европе, 780 в Азии и 294 в Остальная часть мира.

Исследование, которое в конечном итоге привело к разработке хирургической системы да Винчи, было проведено в конце 1980-х годов в некоммерческом исследовательском институте SRI International. В 1990 году SRI получил финансирование от Национальных институтов здравоохранения. SRI разработала прототип роботизированной хирургической системы, которая заинтересовала Управление перспективных исследовательских проектов Министерства обороны США (DARPA), которое интересовалось системой из-за ее потенциала, позволяющего хирургам дистанционно оперировать солдат, раненых на поле боя.


Main settings

Цена ао 386.7
P/E 51.41
P/S 15.83
P/BV 8.56
EV/EBITDA 44.26
EBITDA 1.5775
Сайт http://www.intuitive.com
Число акций ао 0.3574 млрд
Выручка 4.48
Див.доход ао 0
ISIN US46120E6023
Change price per day: 0% (386.7)
Change price per week: +0.9529% (383.05)
Change price per month: -1.4174% (392.26)
Change price per 3 month: +1.1959% (382.13)
Change price per half year: +38.87% (278.46)
Change price per year: +25.57% (307.95)
Change price per 3 year: -63.53% (1060.36)
Change price per 5 year: +126.87% (170.447)
Change price per year to date: +15% (336.26)


All parameters ⇨

Grade

Underestimation

Title Value Grade
P/S 15.83 1
P/BV 8.56 1
P/E 51.41 1
EV/EBITDA 44.26 1
Total:

Efficiency

Title Value Grade
ROA, % 12.66 4
ROE, % 14.73 4
Total:

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total:

Debt

Title Value Grade
Debt/EBITDA 0.041 10
Total:

Growth impulse

Title Value Grade
Profit growth, % -26.69 0
Share price growth, % 35.86 7
Dividend growth, % 0 0
Total:

Insider trading

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
25.04.2024 29.04.2024 RUBASH MARK J
Director
Buy 374.14 212 886 569 0 0 link
25.04.2024 26.04.2024 Beery Joseph C
Director
Buy 375.33 213 563 569 0 0 link
25.04.2024 26.04.2024 Leonard Keith R
Director
Buy 375.33 213 563 569 0 0 link
25.04.2024 26.04.2024 Ladd Amy L
Director
Buy 375.33 213 563 569 0 0 link
25.04.2024 26.04.2024 KANIA DON R
Director
Buy 375.33 213 563 569 0 0 link
26.02.2024 27.02.2024 Rosa David J.
President
Buy 387.16 662 044 1710 0 0 link
26.02.2024 27.02.2024 Samath Jamie
Chief Financial Officer
Buy 387.16 497 113 1284 0 0 link
10.02.2024 12.02.2024 DeSantis Robert
EVP & Chief Strategy & Corp Op
Buy 381.93 365 889 958 0 0 link
10.02.2024 12.02.2024 Widman Fredrik
VP Corporate Controller
Buy 381.93 216 936 568 0 0 link
10.02.2024 12.02.2024 MOHR MARSHALL
Executive VP Global Business S
Buy 381.93 1 097 280 2873 0 0 link
10.02.2024 12.02.2024 Samath Jamie
Chief Financial Officer
Buy 381.93 411 721 1078 0 0 link
10.02.2024 12.02.2024 GUTHART GARY S
CEO
Buy 381.93 1 006 000 2634 0 0 link
07.02.2024 08.02.2024 Rosa David J.
President
Sale 389.28 31 418 800 80710 0 -0.02 link
07.02.2024 08.02.2024 Rosa David J.
President
Buy 52.37 7 376 320 140850 0 0.04 link
29.01.2024 30.01.2024 GUTHART GARY S
CEO
Sale 374.41 1 857 070 4960 0 0 link
29.01.2024 30.01.2024 GUTHART GARY S
CEO
Sale 376.06 9 147 660 24325 0 -0.01 link
29.01.2024 30.01.2024 GUTHART GARY S
CEO
Buy 51.02 1 721 920 33750 0 0.01 link
27.04.2023 28.04.2023 LEVY ALAN J
Director
Buy 301.22 145 188 482 0 0 link
27.04.2023 28.04.2023 Ladd Amy L
Director
Buy 301.22 145 188 482 0 0 link
27.04.2023 28.04.2023 NACHTSHEIM JAMI K
Director
Buy 301.22 145 188 482 0 0 link
27.04.2023 28.04.2023 Reed Monica P
Director
Buy 301.22 145 188 482 0 0 link
27.04.2023 28.04.2023 RUBASH MARK J
Director
Buy 301.22 145 188 482 0 0 link
27.04.2023 28.04.2023 Johnson Amal M
Director
Buy 301.22 145 188 482 0 0 link
27.04.2023 28.04.2023 KANIA DON R
Director
Buy 301.22 145 188 482 0 0 link
27.04.2023 28.04.2023 BARRATT CRAIG H
Director
Buy 301.22 197 299 655 0 0 link
27.04.2023 28.04.2023 Beery Joseph C
Director
Buy 301.22 145 188 482 0 0 link
21.04.2023 24.04.2023 RUBASH MARK J
Director
Sale 297.93 2 423 660 8135 0 0 link
21.04.2023 24.04.2023 RUBASH MARK J
Director
Buy 139.5 1 134 830 8135 0 0 link
21.04.2023 24.04.2023 RUBASH MARK J
Director
Sale 297.92 501 399 1683 0 0 link
21.04.2023 24.04.2023 RUBASH MARK J
Director
Buy 76.6 128 918 1683 0 0 link
26.02.2023 27.02.2023 Rosa David J.
EVP Chief Strategy & Growth Of
Buy 231.74 396 275 1710 0 0 link
26.02.2023 27.02.2023 GUTHART GARY S
President & CEO
Buy 231.74 702 172 3030 0 0 link
15.02.2023 16.02.2023 Samath Jamie
Chief Financial Officer
Buy 240.16 173 636 723 0 0 link
27.01.2023 30.01.2023 DeSantis Robert
EVP & Chief Product Officer
Sale 250 407 250 1629 0 0 link
27.01.2023 30.01.2023 DeSantis Robert
EVP & Chief Product Officer
Buy 178.84 291 330 1629 0 0 link
01.11.2022 02.11.2022 Curet Myriam
EVP & Chief Medical Officer
Sale 250.06 2 000 480 8000 0 0 link
01.11.2022 02.11.2022 Curet Myriam
EVP & Chief Medical Officer
Buy 172.35 1 378 800 8000 0 0 link
21.10.2022 24.10.2022 GUTHART GARY S
President & CEO
Sale 210.84 9 319 760 44203 0 -0.01 link
21.10.2022 24.10.2022 GUTHART GARY S
President & CEO
Buy 63.25 4 269 380 67500 0 0.02 link
26.04.2022 27.04.2022 DeSantis Robert
EVP & Chief Product Officer
Sale 253.04 407 647 1611 0 0 link
26.04.2022 27.04.2022 DeSantis Robert
EVP & Chief Product Officer
Buy 222.43 358 335 1611 0 0 link
15.02.2022 17.02.2022 Charlton Henry L
Senior Vice President & Chief
Buy 284.58 906 656 3186 0 0 link
25.01.2022 26.01.2022 Curet Myriam
EVP & Chief Medical Officer
Sale 263.94 1 583 640 6000 0 -0.01 link
25.01.2022 26.01.2022 Curet Myriam
EVP & Chief Medical Officer
Buy 124.5 747 000 6000 0 0.01 link
24.11.2021 26.11.2021 Johnson Amal M
Director
Sale 333.73 2 502 980 7500 0 -0.01 link
24.11.2021 26.11.2021 Johnson Amal M
Director
Buy 64.36 482 700 7500 0 0.01 link
23.07.2021 26.07.2021 LEVY ALAN J
Director
Sale 967.36 2 418 400 2500 0 0 link
23.07.2021 26.07.2021 LEVY ALAN J
Director
Buy 165.61 414 025 2500 0 0 link
23.07.2021 26.07.2021 Ladd Amy L
Director
Sale 971.64 124 370 128 0 0 link
23.07.2021 26.07.2021 BARRATT CRAIG H
Director
Sale 967.2 1 233 180 1275 0 0 link
23.07.2021 26.07.2021 BARRATT CRAIG H
Director
Buy 161.27 205 619 1275 0 0 link
23.07.2021 26.07.2021 Samath Jamie
SVP of Finance
Sale 971.64 488 735 503 0 0 link
23.07.2021 26.07.2021 Samath Jamie
SVP of Finance
Buy 523.65 263 396 503 0 0 link
23.07.2021 26.07.2021 DeSantis Robert
EVP & Chief Product Officer
Sale 967.26 3 872 910 4004 0 0 link
23.07.2021 26.07.2021 DeSantis Robert
EVP & Chief Product Officer
Buy 602.79 837 275 1389 0 0 link
22.04.2021 23.04.2021 Beery Joseph C
Director
Buy 875.53 223 260 255 0 0 link
22.04.2021 23.04.2021 Johnson Amal M
Director
Buy 875.53 223 260 255 0 0 link
28.02.2021 02.03.2021 GUTHART GARY S
President & CEO
Buy 750 966 750 1289 0 0 link

Main owners

Institutions Volume Share, %
Vanguard Group Inc 30375494 8.57
Blackrock Inc. 29243893 8.25
Price (T.Rowe) Associates Inc 16973266 4.79
State Street Corporation 14960837 4.22
FMR, LLC 7539646 2.13
AllianceBernstein L.P. 7299592 2.06
Capital World Investors 7210635 2.03
Geode Capital Management, LLC 6938605 1.96
Bank Of New York Mellon Corporation 6706824 1.89
JP Morgan Chase & Company 5210598 1.47

Contained in ETF

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Evolved U.S. Healthcare Staples ETF 3.14 31.23 0.71
Collaborative Investment Series Trust Trend Aggregation US Fund 1.37 4.03 20.07
Direxion Fallen Knives ETF 4.7 49.48 6.08
Invesco S&P 500® Equal Weight Health Care ETF 2.08 32.90 0.64
Future Health ETF 3.01
First Trust Nasdaq Lux Digital Health Solutions ETF 8.74
FinEx USA UCITS ETF 0.31 54.54
FinEx RUB GLOBAL EQUITY UC ETF 0.08 48.06
FinEx USD GLOBAL EQUITY UC ETF 0.08 37.73
ProShares MSCI Transformational Changes ETF 2.19 0.67
IQ Winslow Focused Large Cap Growth ETF 4.02 0.88
ETC 6 Meridian Quality Growth ETF 3.61 0.02
Guru Favorite Stocks ETF 3.31 0.07
IQ Winslow Large Cap Growth ETF 2.68 0.01
Goldman Sachs Future Health Care Equity ETF 4.51 0.53
Franklin Intelligent Machines ETF 4.82 43.57
Neuberger Berman Disrupters ETF 4.34
Alger 35 ETF 2.99 0.01
Fidelity Digital Health ETF 4.54 0.04
Health Care Select Sector SPDR Fund 2.53 28.02 1.54
Vanguard Health Care ETF 2.26 29.53 1.32
Capital Group Growth ETF 2.07 0.36
iShares U.S. Medical Devices ETF 12.08 30.97 0.54
iShares Global Healthcare ETF 1.81 23.74 1.31
iShares U.S. Healthcare ETF 2.43 29.01 3.42
Fidelity MSCI Health Care Index ETF 2.22 29.23 1.35
Global X Robotics & Artificial Intelligence ETF 7.91 35.90 0.18
ROBO Global Robotics & Automation Index ETF 1.77 40.27 0.05
T. Rowe Price Blue Chip Growth ETF 1.47 22.97
Inspire 100 ETF 3.82 36.32 0.95
AB Disruptors ETF 1.96
Invesco AI and Next Gen Software ETF 4.61
ClearBridge Large Cap Growth ESG ETF 1.93 23.91 0.10
American Century Focused Dynamic Growth ETF 3.92 25.59
Direxion Daily Healthcare Bull 3x Shares 2.23 93.37 1.70
Simplify Health Care ETF 3.36 0.92
ProShares Ultra Health Care 1.86 61.62 0.34
T. Rowe Price Growth Stock ETF 1.39 23.48 0.01
ROBO Global Healthcare Technology and Innovation ETF 1.74 43.56
GraniteShares Nasdaq Select Disruptors ETF 2.36 0.24
FIS Christian Stock Fund 2.41 0.79

Similar companies



Company management

Head Job title Payment Year of birth
Mr. Marshall L. Mohr Executive Vice President of Global Business Services 1.2M 1956 (68 years)
Mr. David J. Rosa President 1.63M 1968 (56 years)
Mr. Robert DeSantis Executive VP and Chief Strategy & Corporate Operations Officer 1.26M 1966 (58 years)
Mr. Jamie E. Samath Senior VP & CFO 1.01M 1971 (53 years)
Mr. Fredrik Widman VP, Principal Accounting Officer & Corporate Controller N/A
Dr. Gary S. Guthart Ph.D. CEO & Director 2.62M 1966 (58 years)
Mr. Henry L. Charlton Senior VP & Chief Commercial and Marketing Officer 1.08M 1970 (54 years)
Mr. Gary H. Loeb J.D. Senior VP, General Counsel & Chief Compliance Officer N/A 1970 (54 years)
Dr. Myriam J. Curet McAdams F.A.C.S., M.D. Executive VP & Chief Medical Officer 1.19M 1957 (67 years)
Dr. Christopher R. Carlson Ph.D. Senior Vice President of Research, Corporate Development & Intuitive Ventures N/A

About company

Address: United States, Sunnyvale, CA -, 1020 Kifer Road - open in Google maps, open in Yandex maps
Website: http://www.intuitive.com
Phone: +408 523 2100